AC-101 tablets for ulcerative colitis
Part of Digestive system clinical trials.
This trial tests an oral tablet called AC-101 for people with moderate to severe ulcerative colitis. It aims to see if the drug can reduce inflammation in the colon and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have had ulcerative colitis for at least 3 months, confirmed by a colonoscopy and biopsy.
- Your colitis is moderate to severe, affecting at least 15 cm of your colon from the anus.
- You have tried other treatments (like biologics or conventional therapies) that did not work.
- You are not pregnant or breastfeeding, and you agree to use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
This trial tests an experimental capsule called INT-210 for people with active ulcerative colitis (UC) who haven't improved enough with standard treatments. It aims to see if the drug can help control symptoms and improve the condition.
This trial tests an experimental drug called ENC1018 for people with moderate-to-severe ulcerative colitis who haven't responded well to standard treatments. It aims to see if the drug is safe and works well.
This study tests an investigational oral drug for ulcerative colitis. It is an early-stage trial to check safety and how the drug is processed by the body in both healthy volunteers and patients with active ulcerative colitis.
This trial tests an investigational drug called LIV001 in people with mild-to-moderate ulcerative colitis. It aims to see if the medicine can help calm inflammation in the colon and improve symptoms.
This trial tests whether adding a probiotic supplement and trace elements to your current treatment helps manage mild to moderate ulcerative colitis. It aims to see if these additions can improve symptoms and quality of life.
Hear when a new Ulcerative Colitis (UC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.